Methyl iodide → Racemic (3-(benzyloxycarbonylamino)-4-(3-bromo-2-methylphenylamino)-4-oxobutyl)dimethylsulfonium iodide

HRID 661900Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 661900
[Br:1][C:2]1[C:3]([CH3:27])=[C:4]([NH:8][C:9](=[O:26])[CH:10]([NH:15][C:16](=[O:25])[O:17][CH2:18][C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[CH2:11][CH2:12][S:13][CH3:14])[CH:5]=[CH:6][CH:7]=1.[I:28][CH3:29]>C(Cl)Cl>[I-:28].[CH2:18]([O:17][C:16]([NH:15][CH:10]([C:9]([NH:8][C:4]1[CH:5]=[CH:6][CH:7]=[C:2]([Br:1])[C:3]=1[CH3:27])=[O:26])[CH2:11][CH2:12][S+:13]([CH3:29])[CH3:14])=[O:25])[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1

Komponenten

4

Edukt 2

HCID 6328Methyl iodideHCID 66606795Racemic benzyl 1-(3-bromo-2-methylphenylamino)-4-(methylthio)-1-oxobutan-2-ylcarbamate

Produkt 1

HCID 87071307Racemic (3-(benzyloxycarbonylamino)-4-(3-bromo-2-methylphenylamino)-4-oxobutyl)dimethylsulfonium iodideAusbeute 101,7 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

Step 2 A mixture of racemic benzyl 1-(3-bromo-2-methylphenylamino)-4-(methylthio)-1-oxobutan-2-ylcarbamate (1.31 g, 2.90 mmol) and DCM (4 mL) was diluted with iodomethane (7.5 mL, 120 mmol) and the mixture was stirred at rt. After 24.5 h, the mixture (a solution with an insoluble reddish oil) was concentrated under vacuum. The residue was treated three times with DCM and concentrated under vacuum to provide racemic (3-(benzyloxycarbonylamino)-4-(3-bromo-2-methylphenylamino)-4-oxobutyl)dimethylsulfonium iodide as an orange-yellow glassy foam (1.75 g, 97%). 1H NMR (400 MHz, chloroform-d) 69.16 (1H, br. s.), 7.28-7.46 (7H, m), 6.99 (1H, t, J=8.0 Hz), 6.71 (1H, d, J=6.8 Hz), 5.11 (2H, s), 4.84 (1H, br. s.), 3.75 (1H, br. s.), 3.54 (1H, br. s.), 3.14 (3H, br. s.), 2.96 (3H, s), 2.75 (1H, br. s.), 2.33-2.41 (1H, m), 2.30 (3H, br. s.). Mass spectrum m/z 465, 467 (M)+.

Aufarbeitung

  1. concentrationthe mixture (a solution with an insoluble reddish oil) was concentrated under vacuum
  2. additionThe residue was treated three times with DCM
  3. concentrationconcentrated under vacuum

Quellen und Nachweise

ORD-Eintrag
ord-b7173c514b6e46f68940b59ffd194835
Quelldatensatz
uspto-grants-2011_12
Patentnummer
US08084620B2

Notizen zur Reaktion

Wird geladen…